Fresenius Kidney Care-Oxford is a medicare approved dialysis facility center in Sutton, Massachusetts and it has 13 dialysis stations. It is located in Worcester county at 10a Galaxy Pass, Sutton, MA, 01590. You can reach out to the office of Fresenius Kidney Care-Oxford at (508) 865-6503. This dialysis clinic is managed and/or owned by Fresenius Medical Care. Fresenius Kidney Care-Oxford has the following ownership type - Profit. It was first certified by medicare in November, 2019. The medicare id for this facility is 222596 and it accepts patients under medicare ESRD program.
Dialysis Center Profile
| Name | Fresenius Kidney Care-Oxford |
|---|
| Location | 10a Galaxy Pass, Sutton, Massachusetts |
|---|
| No. of Dialysis Stations | 13 |
|---|
| Medicare ID | 222596 |
|---|
| Managed By | Fresenius Medical Care |
|---|
| Ownership Type | Profit |
|---|
| Late Shifts | No |
|---|
NPI Associated with this Dialysis Facility:
Dialysis facilities may have several NPI numbers. We have found possible NPI numbers associated with Fresenius Kidney Care-Oxford
from NPPES records by matching their name, address or phone number, so please use this information accordingly.
| NPI Number | 1801448725 |
| Match | Possible same name, address or phone number |
| Organization Name | Bio-medical Applications of Massachusetts, Inc. |
| Doing Business As | Fresenius Kidney Care - Oxford |
| Address | 10 Galaxy Pass Ste A, Sutton, Massachusetts 01590 |
| Phone Number | (508) 865-6503 |
Services Offered
Patient Distribution
Anemia Management
| Dialysis patients with Hemoglobin data | 8 |
Dialysis Adequacy
For adult patients on hemodialysis, Kt/V should be at least 1.2 and for peritoneal dialysis at least 1.7; that means they are receiving the right amount of dialysis. For pediatric patients, Kt/V should be at least 1.2 on hemodialysis and 1.8 on peritoneal dialysis.
Higher percentages are better.
- Hemodialysis
| Adult patients getting regular hemodialysis at the center | 62 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 414 |
| Percentage of adult hemodialysis patients with Kt/V greater than or equal to 1.2 | 97 |
Mineral and Bone Disorder
An important goal of dialysis is to maintain normal levels of various minerals
in the body, such as calcium. This shows the percentage of patients
treated at Fresenius Kidney Care-Oxford with elevated calcium levels.
| Patients in the hypercalcemia summary | 66 |
| Hypercalcemia patient months | 464 |
| Percentage of adult patients with serum calcium greater than 10.2 mg/dL | 3 |
| Patients in the serum phosphorus summary | 66 |
| Percentage of patients with serum phosphorus less than 3.5 mg/dL | 7 |
| Percentage of patients with serum phosphorus from 3.5 to 4.5 mg/dL | 18 |
| Percentage of patients with serum phosphorus from 4.6 to 5.5 mg/dL | 25 |
| Percentage of patients with serum phosphorus from 5.6 to 7 mg/dL | 30 |
| Percentage of patients with serum phosphorus greater than 7 mg/dL | 20 |
Vascular Access
The arteriovenous (AV) fistula is considered the best long-term vascular access for hemodialysis because it
allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access.
Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arteriovenous fistula and catheter summaries | 65 |
| Patient months included in arteriovenous fistula and catheter summaries | 488 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistula for their treatment | 68.7 |
| Percentage of patients receiving treatment through a vascular catheter for 90 days or longer | 15 |
Hospitalization Rate
The rate of hospitalization shows you whether patients who were being treated regularly at Fresenius Kidney Care-Oxford were admitted to the
hospital more often (worse than expected), less often (better than expected), or about the same (as expected),
compared to similar patients treated at other centers.
| Standardized Hospitalization Ratio (SHR) Period | January, 2024 - December, 2024 |
| Patients in facility's Hospitalization Summary | 48 |
| Hospitalization Rate in facility | 91.8 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 174.7 |
| Hospitalization Rate: Lower Confidence Limit | 52.2 |
Readmission Rate
The rate of readmission shows you whether patients who were being treated regularly at Fresenius Kidney Care-Oxford
were readmitted more often (worse than expected), less often (better than expected), or
about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standardized Readmission Ratio (SRR) Period | January, 2024 - December, 2024 |
| Readmission Rate in facility | 11.9 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 27.6 |
| Readmission Rate: Lower Confidence Limit | 3.1 |
Transfusion Summary
Patients with anemia require blood transfusions if their anemia is not managed well by their
dialysis center. This information shows whether Fresenius Kidney Care-Oxford's rate of transfusions is better than expected,
as expected, or worse than expected, compared to other centers that treat similar patients.
| Standardized Transfusion Ratio (STrR) Period | January, 2024 - December, 2024 |
| Patients in facility's Transfusion Summary | 16 |
Survival Summary
The rate of mortality shows you whether patients who were being treated regularly at Fresenius Kidney Care-Oxford lived longer than
expected (better than expected), did not live as long as expected (worse than expected), or lived as long as expected (as expected), compared
to similar patients treated at other facilities.
| Standardized Mortality Ratio (SMR) Period | January, 2021 - December, 2024 |
| Patients in facility's Survival Summary | 168 |
| Mortality Rate in facility | 24.8 (As Expected) |
| Mortality Rate: Upper Confidence Limit | 37.9 |
| Mortality Rate: Lower Confidence Limit | 15.5 |